Delivery Order 75F40120D00032-75F40122F19006
Award Date
12/2/21
Potential Completion Date
12/5/22
Potential Value
$100K
Federal Agency
Food and Drug Administration
Awardee
We Pharma, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Two Step
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed price delivery order contract to We Pharma, Inc. doing business as WEP Clinical, a self-certified small disadvantaged business, for the delivery of pharmaceutical drug products. The $182,616.74 award is in support of the FDA's research, regulatory compliance, and emergency response operations, and represents task orders under a larger 5-year, $6 million indefinite delivery contract awarded...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm-fixed price delivery order to We Pharma, Inc., doing business as WEP Clinical, to obtain a reliable source of currently marketed drug products to support FDA research studies for the Generic Drug User Fee Amendments (GDUFA) regulatory science program. The $477,943.82 order, which has no set-aside designation, is part of a larger 5-year, $9.5 million indefinite delivery contract awarded to We...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to We Pharma, Inc., a self-certified small disadvantaged business structured as a limited liability company. The contract, valued at $199,736.69, is for the procurement of drug products to support the FDA's research, regulatory, and emergency response activities. The contract is designated as a total small business...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services, to We Pharma, Inc., a self-certified small disadvantaged business. The $214,914.90 contract is for the provision of "PHYSICOCHEMICAL PRODUCTS" and has a total small business set-aside. The award supports the FDA's regulatory science program and provides pharmaceutical drug products for the agency's research, compliance, and...
This delivery order against the Department of Health and Human Services Food and Drug Administration is for the purpose of obtaining currently marketed drug products for FDA research studies. Awarded on September 30, 2020 to We Pharma, Inc. located in Morrisville, North Carolina, this firm fixed price contract has a potential value of $246,754.22 and period of performance through September 29, 2021. No set-aside designation was applied. We Pharma Inc. will provide the requested drug products...
The Department of Health and Human Services Food and Drug Administration awarded a $250,000 firm fixed price delivery order contract to We Pharma, Inc. of Morrisville, North Carolina. The purpose of this requirement is to obtain currently marketed drug products for FDA research studies. Performance will take place in Morrisville, North Carolina through September 2021. No set-aside designation was applied to this award made under an unidentified contracting vehicle. The prime contractor will...
This is a firm fixed price delivery order issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $6,561,386.54 contract is for a range of clinical and laboratory applied regulatory science services that support the FDA's regulatory science programs and decision-making across product lifecycles. Services include conducting clinical...
Realm Research LLC, a minority-owned small disadvantaged woman-owned small business, was awarded a $34,259 firm fixed price delivery order by the Department of Health and Human Services Food and Drug Administration (FDA). The order is to provide scientific and clinical support services to monitor the conduct and progress of extramural FDA-funded research studies in human subjects overseen by the Center for Drug Evaluation and Research (CDER). This delivery order is part of a larger $1.1...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order for $268,832.00 to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The order is for a "Survey of Domestic and Foreign Finished Pharmaceutical Manufacturing Practice, including Supply Chain for Management Practices for Drug Components, Containers, and Closures" and is issued under the existing Economic Studies of FDA Regulations...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...